APA

Moralès O., Depil S., Mrizak D., Martin N., Ndour P. A., Dufosse F., Miroux C., Coll J., de Launoit Y., Auriault C., Pancre V. & Delhem N. (20120709). EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Moralès Olivier, Depil Stéphane, Mrizak Dhafer, Martin Nathalie, Ndour Papa Alioune, Dufosse Françoise, Miroux Céline, Coll Jean, de Launoit Yvan, Auriault Claude, Pancre Véronique and Delhem Nadira. 20120709. EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Moralès O., Depil S., Mrizak D., Martin N., Ndour P. A., Dufosse F., Miroux C., Coll J., de Launoit Y., Auriault C., Pancre V. and Delhem N. (20120709). EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Moralès Olivier, Depil Stéphane, Mrizak Dhafer, Martin Nathalie, Ndour Papa Alioune, Dufosse Françoise, Miroux Céline, Coll Jean, de Launoit Yvan, Auriault Claude, Pancre Véronique and Delhem Nadira. EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response. : Journal of immunotherapy (Hagerstown, Md. : 1997). 20120709.